Benefit of Repeated Receptor Stimulation as a Spaceflight Medical Tool to Promote Cardiovascular Fitness: Different Orthostatic Paradigms Compared

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|6|4|253-266

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.6, Iss.4, 2005-08, pp. : 253-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for cardiovascular benefit of homocysteine reduction

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk-Benefit Profile of Sibutramine

By Scheen A.J.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 321-334

Adis International

Access to resources Recommend Favorite

Review of Orthostatic Tests on the Safety of Tamsulosin, a Selective α_1A-Adrenergic Receptor Antagonist, Shows Lack of Orthostatic Hypotensive Effects

By Yasukawa K Swarz H Ito Y

The Journal of International Medical Research, Vol. 29, Iss. 3, 2001-05 ,pp. : 236-251

Field House Publishing

Access to resources Recommend Favorite

Gliptins – do they increase cardiovascular risk or benefit?

By Doggrell Sheila A Dimmitt Simon B

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 675-680

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular effects of elgodipine and nifedipine compared in anaesthetized rats

By Valdivielso J.M. Macas J.F. Lopez-Novoa J.M.

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite